| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 成都泰合健康科技集团股份有限公司是以生物制药和高层钢结构为主导,集中西制药、生物制药、动保药业、制造建筑及生物工程技术应用研究、开发、生产、经营一体化的高科技上市公司,是成都市56户重点优势企业.公司拥有美妥昔I131、单抗注射液、EGF冻干滴眼液、LXM氧化底密度脂蛋白监测试剂盒三个国家一类新生物制剂,子公司华神钢构专业从事钢结构建筑的设计、制作、安装和服务,拥有上万平方米的生产厂房和专业化的制造设备。 | ||||||||||||||||||||||||
| Main Business | 中西成药、生物制药及大健康产品的研发、生产和销售，以及钢结构施工业务等 | ||||||||||||||||||||||||
| Legal Representative | 黄明良 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 宁潞宏 | ||||||||||||||||||||||||
| Solicitors | 四川商信律师事务所 | ||||||||||||||||||||||||
| Auditors | 成都市蜀都会计师事务所 | ||||||||||||||||||||||||
| Tel No | 028-66616656;028-66616680 | ||||||||||||||||||||||||
| Fax No | 028-66616656 | ||||||||||||||||||||||||
| Website | www.huasungrp.com | ||||||||||||||||||||||||
| hskj@huasungrp.com；liuqing@huasungrp.com；hsjt@huasungrp.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 27/03/1998 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.040 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.010 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 1.645 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.834B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |